BXP, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BXP, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.48B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.41B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $3.27B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $3.11B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.89B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $2.77B | Feb 27, 2023 |
| FY2019 | Dec 31, 2019 | $757.50M | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $743.55M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $733.74M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $725.77M | Mar 2, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.06B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.04B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.00B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.93B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.81B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $1.69B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.83B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.65B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $1.61B | Mar 2, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $276.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $14.27M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $190.22M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $848.95M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $505.20M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $872.73M | Feb 27, 2023 |
| FY2019 | Dec 31, 2019 | $140.82M | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $107.77M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $164.32M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $98.11M | Mar 2, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $908.11M | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $825.78M | Feb 28, 2018 |
| FY2017 | Dec 31, 2015 | $849.37M | Feb 28, 2018 |
| FY2016 | Dec 31, 2014 | $801.82M | Feb 28, 2017 |
| FY2015 | Dec 31, 2013 | $678.12M | Feb 29, 2016 |
| FY2014 | Dec 31, 2012 | $640.32M | Mar 2, 2015 |
| FY2013 | Dec 31, 2011 | $605.17M | Feb 28, 2014 |
| FY2011 | Dec 31, 2010 | $610.51M | Feb 28, 2012 |
| FY2011 | Dec 31, 2009 | $567.53M | Feb 28, 2012 |
| FY2010 | Dec 31, 2008 | $577.39M | Feb 25, 2011 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.25B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.23B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.30B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.28B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.13B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $1.16B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.18B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.15B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $911.98M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $1.03B | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.17B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $26.08B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $26.03B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $24.21B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $22.37B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $22.86B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $21.28B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $20.26B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $19.37B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $18.85B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.47B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $18.14B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $17.83B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $15.84B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $14.32B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $14.51B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $13.26B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $12.04B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $11.27B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $10.92B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.15B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.41B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $5.88B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $6.13B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $5.83B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $6.00B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $5.68B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $5.88B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $5.81B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $5.79B | Feb 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.67B) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($1.42B) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($816.15M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($391.36M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | ($625.89M) | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | ($509.65M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($760.52M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($675.53M) | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | ($712.34M) | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | ($693.69M) | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.48B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.25B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.53B | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $690.33M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $452.69M | Feb 27, 2025 |
| FY2023 | Dec 31, 2020 | $1.67B | Feb 27, 2024 |
| FY2022 | Dec 31, 2019 | $644.95M | Feb 27, 2023 |
| FY2021 | Dec 31, 2018 | $543.36M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $434.77M | Feb 26, 2021 |
| FY2018 | Sep 30, 2017 | $434.77M | Feb 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $3.30B | Feb 25, 2022 |
| FY2020 | Dec 31, 2020 | $2.93B | Feb 26, 2021 |
| FY2019 | Dec 31, 2019 | $2.95B | Mar 2, 2020 |
| FY2018 | Dec 31, 2018 | $3.00B | Feb 28, 2019 |
| FY2017 | Dec 31, 2017 | $3.01B | Feb 28, 2018 |
| FY2016 | Dec 31, 2016 | $2.03B | Feb 28, 2017 |
| FY2015 | Dec 31, 2015 | $3.36B | Feb 29, 2016 |
| FY2014 | Dec 31, 2014 | $4.17B | Mar 2, 2015 |
| FY2013 | Dec 31, 2013 | $4.26B | Feb 28, 2014 |
| FY2012 | Dec 31, 2012 | $3.06B | Feb 28, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 5 | Feb 27, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 2, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 5 | Feb 27, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 2, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 158.55M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 158.17M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 156.94M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 156.76M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 156.54M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | 155.72M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 154.79M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 154.46M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 154.33M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 153.79M | Feb 28, 2018 |